Terms: = Lung cancer AND SRC, c-SRC, 6714, ENSG00000197122, P12931, ASV, p60-Src, SRC1, c-src AND Prognosis
107 results:
1. Treatment strategies for stage IA non-small cell lung cancer: A SEER-based population study.
Wu B; Zhang X; Feng N; Hu Z; Wu J; Zhou W; Wei Y; Zhang W; Wang K
PLoS One; 2024; 19(4):e0298470. PubMed ID: 38683794
[TBL] [Abstract] [Full Text] [Related]
2. Tyrosine phosphatase
Chen X; Keller SJ; Hafner P; Alrawashdeh AY; Avery TY; Norona J; Zhou J; Ruess DA
Front Immunol; 2024; 15():1340726. PubMed ID: 38504984
[TBL] [Abstract] [Full Text] [Related]
3. RNA-binding protein RPS7 promotes hepatocellular carcinoma progression via LOXL2-dependent activation of ITGB1/FAK/src signaling.
Zhou YJ; Yang ML; He X; Gu HY; Ren JH; Cheng ST; Fu Z; Zhang ZZ; Chen J
J Exp Clin Cancer Res; 2024 Feb; 43(1):45. PubMed ID: 38326908
[TBL] [Abstract] [Full Text] [Related]
4. ING3 inhibits the malignant progression of lung adenocarcinoma by negatively regulating ITGB4 expression to inactivate src/FAK signaling.
Cheng S; Li M; Zheng W; Li C; Hao Z; Dai Y; Wang J; Zhuo J; Zhang L
Cell Signal; 2024 May; 117():111066. PubMed ID: 38281617
[TBL] [Abstract] [Full Text] [Related]
5. Re-expression of epigenetically silenced PTPRR by histone acetylation sensitizes RAS-mutant lung adenocarcinoma to SHP2 inhibition.
Du T; Hu X; Hou Z; Wang W; You S; Wang M; Ji M; Xue N; Chen X
Cell Mol Life Sci; 2024 Jan; 81(1):64. PubMed ID: 38280930
[TBL] [Abstract] [Full Text] [Related]
6. The emerging roles of CEACAM6 in human cancer (Review).
Wu G; Wang D; Xiong F; Wang Q; Liu W; Chen J; Chen Y
Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38240103
[TBL] [Abstract] [Full Text] [Related]
7. Comprehensive analysis of mitophagy-related genes in NSCLC diagnosis and immune scenery: based on bulk and single-cell RNA sequencing data.
Yu H; Liu Q; Jin M; Huang G; Cai Q
Front Immunol; 2023; 14():1276074. PubMed ID: 38155968
[TBL] [Abstract] [Full Text] [Related]
8. A multiomic investigation of lung adenocarcinoma molecular subtypes.
Liang KH; Luo YH; Wang ML; Chiou SH; Chen YM; Hsu HS
J Chin Med Assoc; 2024 Jan; 87(1):33-39. PubMed ID: 37991388
[TBL] [Abstract] [Full Text] [Related]
9. Crosstalk with lung fibroblasts shapes the growth and therapeutic response of mesothelioma cells.
Chrisochoidou Y; Roy R; Farahmand P; Gonzalez G; Doig J; Krasny L; Rimmer EF; Willis AE; MacFarlane M; Huang PH; Carragher NO; Munro AF; Murphy DJ; Veselkov K; Seckl MJ; Moffatt MF; Cookson WOC; Pardo OE
Cell Death Dis; 2023 Nov; 14(11):725. PubMed ID: 37938546
[TBL] [Abstract] [Full Text] [Related]
10. Integrated bioinformatics and network pharmacology to explore the therapeutic target and molecular mechanisms of Taxus chinensis against non-small cell lung cancer.
Zhang S; Wang J; Zhang H
Medicine (Baltimore); 2023 Nov; 102(44):e35826. PubMed ID: 37933017
[TBL] [Abstract] [Full Text] [Related]
11. Network module analysis and molecular docking-based study on the mechanism of astragali radix against non-small cell lung cancer.
Xiao W; Xu Y; Baak JP; Dai J; Jing L; Zhu H; Gan Y; Zheng S
BMC Complement Med Ther; 2023 Sep; 23(1):345. PubMed ID: 37770919
[TBL] [Abstract] [Full Text] [Related]
12. Rucaparib inhibits lung adenocarcinoma cell proliferation and migration via the SHCBP1/CDK1 pathway.
Dai Y; Hu C; Zhou H; Liu W; Lai W; Xu R; Liao J; Wang J; Li G; Zhang R
FEBS J; 2023 Dec; 290(24):5720-5743. PubMed ID: 37581853
[TBL] [Abstract] [Full Text] [Related]
13. Network pharmacology and bioinformatics analysis identifies potential therapeutic targets of
Wu WY; Jiao X; Song WX; Wu P; Xiao PQ; Huang XF; Wang K; Zhan SF
Front Endocrinol (Lausanne); 2023; 14():1187882. PubMed ID: 37347115
[TBL] [Abstract] [Full Text] [Related]
14. FAM3C in circulating tumor-derived extracellular vesicles promotes non-small cell lung cancer growth in secondary sites.
Thuya WL; Kong LR; Syn NL; Ding LW; Cheow ESH; Wong RTX; Wang T; Goh RMW; Song H; Jayasinghe MK; Le MT; Hu JC; Yong WP; Lee SC; Wong AL; Sethi G; Hung HT; Ho PC; Thiery JP; Sze SK; Guo T; Soo RA; Yang H; Lim YC; Wang L; Goh BC
Theranostics; 2023; 13(2):621-638. PubMed ID: 36632230
[No Abstract] [Full Text] [Related]
15. Targeting src reactivates pyroptosis to reverse chemoresistance in lung and pancreatic cancer models.
Su L; Chen Y; Huang C; Wu S; Wang X; Zhao X; Xu Q; Sun R; Kong X; Jiang X; Qiu X; Huang X; Wang M; Wong PP
Sci Transl Med; 2023 Jan; 15(678):eabl7895. PubMed ID: 36630483
[TBL] [Abstract] [Full Text] [Related]
16. Proteomic Profiling of Small Extracellular Vesicles Isolated from the Plasma of Vietnamese Patients with Non-Small Cell lung cancer Reveals Some Potential Biomarkers.
Bui TP; Le PL; Nguyen LTT; Tho LT; Trinh TH
Asian Pac J Cancer Prev; 2022 Jun; 23(6):1893-1900. PubMed ID: 35763629
[TBL] [Abstract] [Full Text] [Related]
17. MPZL1 upregulation promotes tumor metastasis and correlates with unfavorable prognosis in non-small cell lung cancer.
Feng J; Ouyang H; Wang J; Pan D; Sheng L; Xu C; Lin W; Hu D; Chang C; Jia D
Carcinogenesis; 2022 Nov; 43(10):919-929. PubMed ID: 35727197
[TBL] [Abstract] [Full Text] [Related]
18. SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma.
Zhang X; Wu Z; Ma K
BMC Cancer; 2022 Apr; 22(1):406. PubMed ID: 35421944
[TBL] [Abstract] [Full Text] [Related]
19. Cell-penetrating peptides containing the progesterone receptor polyproline domain inhibits EGF signaling and cell proliferation in lung cancer cells.
Kaewjanthong P; Sooksai S; Sasano H; Hutvagner G; Bajan S; McGowan E; Boonyaratanakornkit V
PLoS One; 2022; 17(3):e0264717. PubMed ID: 35235599
[TBL] [Abstract] [Full Text] [Related]
20. cancer cell-derived exosomal circUSP7 induces CD8
Chen SW; Zhu SQ; Pei X; Qiu BQ; Xiong D; Long X; Lin K; Lu F; Xu JJ; Wu YB
Mol Cancer; 2021 Nov; 20(1):144. PubMed ID: 34753486
[TBL] [Abstract] [Full Text] [Related]
[Next]
